• Skip to secondary menu
  • Skip to main content
  • Skip to primary sidebar
  • Home
  • About
  • Stay In Touch

2Article

Just Read, Search and Publish Articles

  • Business
  • Finance & Career
  • Lifestyle
  • Travel
  • Home & Family
  • Health
You are here: Home / Health / Anti Aging / CD31 antibody may help to develop novel cardiovascular therapies

CD31 antibody may help to develop novel cardiovascular therapies

August 22, 2011 by Nick Bella

CD31, also known as PECAM1 (platelet endothelial cell adhesion molecule 1), encodes a type I integral membrane protein and member of the immunoglobulin receptor superfamily. The CD31 antibody is widely used as an endothelial marker.

CD31 is expressed on a number of cell types, including macrophages, lymphocytes and endothelial cells, and is specifically concentrated at endothelial junctions. CD31 antibody studies have shown PECAM1 is also expressed in a number of soft tissue, vascular and endothelial tumours; the CD31 antibody database is a useful source of endothelial markers when studying angiogenesis in connection with tumour recurrence.

CD31 is expressed on the membranes of some endothelial blood-vessel cells. Recently, cardiologist Young-sup Yoon, of Emory University, published a CD31 antibody study suggesting CD31 may be significant in developing new cardiovascular therapies.

In Yoon’s study, the CD31 antibody was used in both donated human blood and mouse bone marrow cells to detect and isolate CD31(+) endothelial cells. Using an in vivo mouse model of PVD (peripheral vascular disease), it was seen that CD31(+) cells secreted hormones which supported the growth of new vasculature, enabling continued circulation through the legs. In vitro, CD31(+) cells were shown to mimic the growth of new blood vessels by developing tubular structures.

It was suggested that harvesting CD31-positive cells had several advantages over stem cells. They can be grown quickly, and do not require large volumes of patient blood or bone marrow. It is hoped the research may pave the way for novel cardiovascular disease treatments in the future.

We at Novus Biologicals have an extensive antibody database to support vascular research, to which we recently added a new CD31 antibody.

About Author

The Article is written by novusbio.com providing antibody database and Antibodies Services. Visit http://www.novusbio.com for more information on novusbio.com Products & Services
___________________________

Copyright information

This article is free for reproduction but must be reproduced in its entirety, including live links & this copyright statement must be included. Visit novusbio.com for more services!

Filed Under: Anti Aging

Primary Sidebar

Who We Are

2Article.com is a leading public blog which analyzes the latest news, stories and articles.

Latest Buzz

  • Materials Commonly Used in Inflatable Advertising and Why They Matter
  • What Do HVHZ Impact Window Ratings Mean for Clearwater Homes?
  • Weekend Cottage Getaways in Malvern for Couples and Families
  • How Small Businesses Benefit from Custom Printed Packaging
  • How to Pair Designer Radiators with Underfloor Heating
  • Maintaining Your House Awning for Year-Round Use
  • 3 Digital Marketing Strategies That Help Roofers Outbook the Competition
  • Support Mental Health and Safety By Advancing Transgender Rights
  • Solo Traveling to Kasol: Tips, Safety, and Best Experience
  • Digital Signage vs. Traditional Signs in West London Businesses
  • How to Avoid Common Mistakes When Hiring a Skip
  • Wondering How Grab Lorry Hire Can Save You Time and Money? Find Out Now!
  • Causeway Bay: Top 3 Reasons To Book A Hotel Within The Vicinity
  • Health Benefits And Nutrition Facts Of Blueberries
  • How Removal Companies Ensure Timely Delivery of Goods

Copyright © 2026 · Lifestyle Pro on Genesis Framework · WordPress · Log in